Annual Results for the FY 2025-26 and Corporate Update
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Deccan Health Care Ltd reported strong annual results for FY 2025-26. Standalone revenue grew 18.7% to ₹891.71 million (from ₹751.32 million), while net profit nearly doubled, rising 91.2% to ₹22.90 million (from ₹11.98 million). EPS improved from ₹0.56 to ₹0.93, up 66.1%. On a consolidated basis, revenue rose 9.1% to ₹819.05 million and net profit surged 114.7% to ₹24.88 million. The company attributed performance to improving margins, operational efficiencies, and cost discipline — with net profit margin expanding from 1.59% to 2.57%. Deccan manufactures preventive nutrition products at its Uttarakhand facility and distributes via Wellness Marts, online platforms, and export markets.
Sharply improved profitability and margins signal stronger operational leverage. Revenue growth alongside even faster profit growth suggests improving unit economics, which could be positive for the stock at current levels.